NCT05863611

Brief Summary

The purpose of our work; To investigate the effect of frailty on balance and fall risk in individuals with type 2 diabetes.The reason why participants the investigators invited to the study is participants diagnosis of Type 2 Diabetes.During the research, a questionnaire form (age, gender, educational status, etc.) in which participants demographic information will be recorded for evaluation purposes and a consent form for participation in the study will be filled. Standardized Mini Mental Test will be applied. Then fragility will be evaluated with the Fried Fragility Index. Fall assessment will be assessed with the Fall Risk Self-Assessment Scale and balance assessment will be made with the Tinetti Balance. participants will not need to spend a long time for all assessments. The time required for the assessment will be around 30 minutes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

May 20, 2023

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2023

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2023

Completed
Last Updated

May 18, 2023

Status Verified

May 1, 2023

Enrollment Period

5 days

First QC Date

January 11, 2023

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frailty has an effect on balance in patients with type 2 diabetes.

    Balance assessment will be made with the Tinetti Balance

    march 15, 2023 - june 10 , 2023

Secondary Outcomes (1)

  • Frailty has an effect on the risk of falling in patients with type 2 diabetes.

    march 15, 2023 - june 10 , 2023

Study Arms (2)

25 individuals with frailty syndrome with type 2 diabetes

Other: arms

25 individuals without frailty syndrome with type 2 diabetes

Other: arms

Interventions

armsOTHER

During the research, a questionnaire form (age, gender, educational status, etc.) in which your demographic information will be recorded for evaluation purposes and a consent form for participation in the study will be filled. Standardized Mini Mental Test will be applied. Then fragility will be evaluated with the Fried Fragility Index. Fall assessment will be assessed with the Fall Risk Self-Assessment Scale. Balance assessment will be made with the Tinetti Balance and Gait Assessment.

25 individuals with frailty syndrome with type 2 diabetes25 individuals without frailty syndrome with type 2 diabetes

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

be diagnosed with type 2 diabetes be over 65 years old

You may qualify if:

  • Diagnosed with diabetes
  • Being 65 years or older
  • Not having a cooperation problem,
  • No communication difficulties or problems voluntarily accepting participation in the research

You may not qualify if:

  • \- Those with uncontrollable hypertension, heart disease, cardiac arrhythmia
  • Those with cardiovascular disease
  • Those who have malignancy and cause malignancy, chemotherapy, radiotherapy
  • Those with any neurological or orthopedic disorders
  • Those who have had an operation in the last 6 months
  • Those on bed rest
  • Individuals addicted to alcohol and drugs
  • Those who do not agree to participate in the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulsah Turanoglu

Kırıkkale, Merkez, 71000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 11, 2023

First Posted

May 18, 2023

Study Start

May 20, 2023

Primary Completion

May 25, 2023

Study Completion

June 10, 2023

Last Updated

May 18, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
march 15,2023 - june 10,2023

Locations